Chimerix Appoints Linda M. Richardson as Chief Commercial Officer DURHAM, N.C., Dec. 18, 2013 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
Audax Health Names David Ko President and Chief Operating Officer WASHINGTON, D.C. (DECEMBER 19, 2013) — Audax Health, a digital health development company that empowers consumers to lead healthier lives, today announced that board member David Ko will assume the role...
European Medicines Agency Accepts Marketing Authorization Application for Dalbavancin CHICAGO, Dec. 23, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX) today announced that the European Medicines Agency (EMA) has accepted for review a Marketing...
ZIO® Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine SAN FRANCISCO – January 2, 2014 – iRhythm Technologies, a healthcare information services...
Convergence Pharmaceuticals and Consortium Partners Win European Commission FP7 Grant for the PROPANE Project Cambridge, UK, 8 January 2014: Convergence Pharmaceuticals Limited (“Convergence”), the company focused on the development of novel and high value...
Recent Comments